- Net Income: China National Chemical reported a net income of 2.84 billion yuan for the first half of 2024.
- Revenue: The company’s revenue reached 90.61 billion yuan in the same period.
- Analyst Recommendations: Analysts have given 15 buys for the company with no holds or sells.
A look at China National Chemical Engineering Company A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China National Chemical Engineering Company A, a construction services provider, is positioned for a positive long-term outlook based on its Smartkarma Smart Scores. With an impressive Value score of 5, the company is deemed to be undervalued in the market. Coupled with solid scores in Dividend, Growth, Resilience, and Momentum, China National Chemical Engineering Company A demonstrates strong fundamentals and potential for sustainable growth.
The company specializes in constructing chemical, petrochemical, pharmaceutical, power plants, and coal industry facilities. With above-average scores across key factors influencing its outlook, China National Chemical Engineering Company A appears well-equipped to navigate market challenges and capitalize on emerging opportunities in the construction sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
